Boundary Creek Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-175,000
Closed -$9.03M 50
2022
Q3
$9.03M Buy
175,000
+10,000
+6% +$593K 0.25% 27
2022
Q2
$8.67M Buy
+165,000
New +$11.5M 0.55% 11

Other funds holding THC

Boundary Creek Advisors's THC Position: Q4 2022 in Review

Boundary Creek Advisors sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 175,000 shares — an estimated $9.03M sold.

Boundary Creek Advisors first reported a position in THC in Q2 2022 and held it in 2 quarters. The position peaked at $9.03M in Q3 2022. 355 funds tracked by Wall St. Rank hold THC as of Q4 2022.

  • Boundary Creek Advisors reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
  • Boundary Creek Advisors sold 175,000 Tenet Healthcare shares in Q4 2022, an estimated $9.03M.
  • Boundary Creek Advisors first reported a position in Tenet Healthcare in Q2 2022 and held it in 2 quarters.
  • Boundary Creek Advisors's Tenet Healthcare position peaked at $9.03M in Q3 2022.
  • 355 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.

Based on Boundary Creek Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.